Correspondence 0001493152-24-031322 from IMPACT BIOMEDICAL INC. (IBO)

IMPACT BIOMEDICAL INC.
Date: Aug. 12, 2024 · CIK: 0001834105 · Accession: 0001493152-24-031322

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-275062

Date

Aug. 12, 2024

Author

Revere

Form

CORRESP

Company

IMPACT BIOMEDICAL INC.

Letter

Via Edgar United States Securities and Exchange Commission Division of Corporation Finance Attention: Daniel Crawford Re: Impact BioMedical Inc. Registration Statement on Form S-1, as amended File No. 333-275062

Dear Mr. Crawford:

Reference is made to our letter, filed as correspondence via EDGAR on August 8, 2024, in which we requested the acceleration of the effective date of the above referenced Registration Statement. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Please feel free to direct any questions or comments concerning this request to our counsel, Scott Linsky of Lucosky Brookman LLP, at (732) 395-4408.

Sincerely,
Revere
Securities, LLC

Show Raw Text

CORRESP
1
filename1.htm

REVERE
SECURITIES, LLC

560
Lexington Avenue, 16th Floor

New
York, New York 10022

August
12, 2024

Via
Edgar

United
States Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, NE

Washington,
D.C. 20549

Attention:
Daniel Crawford

Re:
Impact BioMedical Inc.

Registration
Statement on Form S-1, as amended

File
No. 333-275062

Dear
Mr. Crawford:

Reference
is made to our letter, filed as correspondence via EDGAR on August 8, 2024, in which we requested the acceleration of the effective date
of the above referenced Registration Statement. We are no longer requesting that such Registration Statement be declared effective at
this time and we hereby formally withdraw our request for acceleration of the effective date.

Please
feel free to direct any questions or comments concerning this request to our counsel, Scott Linsky of Lucosky Brookman LLP, at (732)
395-4408.

    Sincerely,

    Revere
    Securities, LLC

    /s/ Bill Moreno

    By:

    Bill
    Moreno

    Title:

    Chairman
    & CEO

SecProbe.io